|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Life Science | 539M | 699M | 938M | 807M | 1.73B | |||||
Total Assets | 1.94B | 1.71B | 1.9B | 1.71B | 2.9B | |||||
Interest Expense | -86.02M | -90.87M | -129M | -170M | -152M | |||||
Income Tax Expense | 5.56M | -28.47M | -69.51M | 176K | 13.98M | |||||
CAPEX | -85.33M | -152M | -28.44M | -6.5M | -8.86M | |||||
EBT | -518M | -587M | -696M | -363M | 697M | |||||
D&A | 64.13M | 129M | 237M | 75.66M | 38.82M | |||||
Operating Income | -374M | -447M | -440M | -303M | 867M | |||||
Net Income | -524M | -559M | -627M | -363M | 683M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 297M | 499M | 532M | 413M | 1.49B | |||||
Total Assets | 1.74B | 1.47B | 1.58B | 1.34B | 2.53B | |||||
| - | - | - | - | 236M | ||||||
Outside of the United States | 242M | 200M | 406M | 394M | 236M | |||||
Total Assets | 194M | 232M | 313M | 362M | 374M | |||||
| - | - | - | - | 1.49B |
- Stock Market
- Stocks
- PTCT Stock
- P91 Stock
- Financials PTC Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
